Straying from the path in neuro-oncology.
作者信息
Villano J Lee, Pittman Thomas
机构信息
Departments of Internal Medicine and Neurology, Markey Cancer Center, University of Kentucky, Lexington, Kentucky (J.L.V.); Department of Neurosurgery, Markey Cancer Center, University of Kentucky, Lexington, Kentucky (T.P.).
出版信息
Neuro Oncol. 2014 Aug;16(8):1155-6. doi: 10.1093/neuonc/nou108. Epub 2014 Jun 18.
Abstract
摘要
相似文献
1
Straying from the path in neuro-oncology.偏离神经肿瘤学的道路。
Neuro Oncol. 2014 Aug;16(8):1155-6. doi: 10.1093/neuonc/nou108. Epub 2014 Jun 18.
2
Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.2013年神经肿瘤学会年会及世界神经肿瘤联合会四年一度会议的最新消息。
Tumori. 2014 May-Jun;100(3):358-62. doi: 10.1700/1578.17228.
3
Spanish co-operative group of Medical Neuro-oncology (GENOM).西班牙医学神经肿瘤学合作组织（GENOM）
Clin Transl Oncol. 2006 Oct;8(10):770. doi: 10.1007/s12094-006-0128-3.
4
Neuro-oncology: treatment decisions in elderly patients with glioblastoma.神经肿瘤学：老年胶质母细胞瘤患者的治疗决策
Nat Rev Neurol. 2012 Dec;8(12):664-5. doi: 10.1038/nrneurol.2012.220. Epub 2012 Nov 13.
5
Neuro-oncology, a decade of temozolomide and beyond.神经肿瘤学，替莫唑胺应用的十年及以后。
Expert Rev Anticancer Ther. 2010 Nov;10(11):1675-7. doi: 10.1586/era.10.161.
6
Prime time for molecular marker diagnostics in neuro-oncology.
Curr Opin Neurol. 2012 Dec;25(6):743-4. doi: 10.1097/WCO.0b013e32835a0247.
7
[Neuro-oncology].[神经肿瘤学]
Nervenarzt. 2015 Jun;86(6):671. doi: 10.1007/s00115-014-4170-z.
8
[Research and therapeutic trials on gliomas].[胶质瘤的研究与治疗试验]
Soins. 2009 Mar(733):51.
9
[Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].[放疗联合替莫唑胺治疗后脑转移性黑色素瘤的完全缓解]
Med Clin (Barc). 2002 Nov 30;119(19):758-9. doi: 10.1016/s0025-7753(02)73570-7.
10
Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.同步放化疗后辅助使用替莫唑胺可提高多形性胶质母细胞瘤患者的生存率。
Curr Neurol Neurosci Rep. 2005 May;5(3):167-8. doi: 10.1007/s11910-005-0043-y.
本文引用的文献
1
A randomized trial of bevacizumab for newly diagnosed glioblastoma.贝伐珠单抗治疗新诊断的胶质母细胞瘤的随机试验。
N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573.
2
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.替莫唑胺、洛莫司汀和长春新碱治疗少突胶质细胞瘤获益与 IDH 突变相关。
J Clin Oncol. 2014 Mar 10;32(8):783-90. doi: 10.1200/JCO.2013.49.3726. Epub 2014 Feb 10.
3
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.替莫唑胺剂量密集疗法治疗新诊断的胶质母细胞瘤：一项随机 III 期临床试验。
J Clin Oncol. 2013 Nov 10;31(32):4085-91. doi: 10.1200/JCO.2013.49.6968. Epub 2013 Oct 7.
4
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.三期临床试验：放化疗治疗间变性少突胶质细胞瘤：RTOG9402 的长期结果。
J Clin Oncol. 2013 Jan 20;31(3):337-43. doi: 10.1200/JCO.2012.43.2674. Epub 2012 Oct 15.
5
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.替莫唑胺辅助治疗新诊断的间变性少突胶质细胞瘤：欧洲癌症研究与治疗组织脑肿瘤研究组 26951 号研究的长期随访。
J Clin Oncol. 2013 Jan 20;31(3):344-50. doi: 10.1200/JCO.2012.43.2229. Epub 2012 Oct 15.
6
Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution.替莫唑胺在多形性胶质母细胞瘤患者中的长期辅助治疗：单中心经验。
J Cancer Res Clin Oncol. 2010 Nov;136(11):1691-5. doi: 10.1007/s00432-010-0827-6. Epub 2010 Feb 23.
7
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.替莫唑胺长期治疗高级别胶质瘤患者的安全性和可行性。
Neurology. 2007 Feb 27;68(9):688-90. doi: 10.1212/01.wnl.0000255937.27012.ee.
8
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.立体定向放射外科联合全脑放射治疗与单纯立体定向放射外科治疗脑转移瘤的随机对照试验
JAMA. 2006 Jun 7;295(21):2483-91. doi: 10.1001/jama.295.21.2483.
9
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.放疗联合同步及辅助替莫唑胺治疗胶质母细胞瘤
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
10
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.对于有一至三个脑转移瘤的患者，采用全脑放射治疗联合或不联合立体定向放射外科强化治疗：RTOG 9508随机试验的III期结果
Lancet. 2004 May 22;363(9422):1665-72. doi: 10.1016/S0140-6736(04)16250-8.
Zotero 插件